14.51
price down icon0.68%   -0.10
after-market After Hours: 14.51
loading
Elanco Animal Health Inc stock is traded at $14.51, with a volume of 3.80M. It is down -0.68% in the last 24 hours and up +3.72% over the past month. Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$14.61
Open:
$14.64
24h Volume:
3.80M
Relative Volume:
0.66
Market Cap:
$7.21B
Revenue:
$4.45B
Net Income/Loss:
$205.00M
P/E Ratio:
36.27
EPS:
0.4
Net Cash Flow:
$372.00M
1W Performance:
-1.83%
1M Performance:
+3.72%
6M Performance:
+20.82%
1Y Performance:
+9.51%
1-Day Range:
Value
$14.38
$14.66
1-Week Range:
Value
$14.38
$15.14
52-Week Range:
Value
$8.02
$15.78

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name
Name
Elanco Animal Health Inc
Name
Phone
877-352-6261
Name
Address
2500 INNOVATION WAY, GREENFIELD
Name
Employee
9,450
Name
Twitter
@Elanco
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ELAN's Discussions on Twitter

Compare ELAN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
ELAN
Elanco Animal Health Inc
14.51 7.34B 4.45B 205.00M 372.00M 0.40
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.54 70.46B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.72 47.78B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.69 45.15B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.01 19.16B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
298.16 13.56B 2.99B 1.21B 1.13B 25.06

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-26-25 Upgrade William Blair Mkt Perform → Outperform
Dec-09-24 Initiated UBS Buy
Dec-02-24 Initiated Leerink Partners Market Perform
Sep-19-24 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-05-24 Upgrade Stifel Hold → Buy
Dec-19-23 Initiated Jefferies Buy
Dec-15-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-07-23 Initiated Exane BNP Paribas Outperform
Apr-20-23 Upgrade Barclays Equal Weight → Overweight
Aug-18-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-16-22 Downgrade JP Morgan Overweight → Neutral
Jul-21-22 Downgrade Goldman Buy → Sell
Jul-12-22 Initiated Piper Sandler Neutral
Nov-18-21 Initiated Morgan Stanley Overweight
Oct-28-21 Downgrade Stifel Buy → Hold
Aug-05-21 Resumed Credit Suisse Outperform
Jun-15-21 Upgrade Cleveland Research Underperform → Neutral
May-11-21 Upgrade Barclays Underweight → Equal Weight
May-11-21 Upgrade Gabelli & Co Hold → Buy
Apr-15-21 Initiated Stifel Buy
Mar-22-21 Downgrade Gabelli & Co Buy → Hold
Feb-26-21 Upgrade Credit Suisse Neutral → Outperform
Dec-09-20 Downgrade Argus Buy → Hold
Nov-09-20 Downgrade Barclays Overweight → Underweight
Aug-20-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-13-20 Resumed Credit Suisse Neutral
Aug-04-20 Resumed Goldman Buy
Jul-27-20 Downgrade Cleveland Research Neutral → Underperform
Apr-02-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-10-20 Initiated Raymond James Mkt Perform
Dec-19-19 Upgrade BofA/Merrill Neutral → Buy
Nov-07-19 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-23-19 Initiated Barclays Overweight
Aug-26-19 Downgrade BofA/Merrill Buy → Neutral
Aug-15-19 Upgrade UBS Sell → Neutral
May-23-19 Initiated Guggenheim Neutral
Mar-18-19 Upgrade BofA/Merrill Neutral → Buy
Mar-13-19 Resumed Morgan Stanley Equal-Weight
Feb-12-19 Initiated William Blair Mkt Perform
Jan-23-19 Initiated UBS Sell
Jan-15-19 Initiated Argus Buy
Oct-15-18 Initiated Morgan Stanley Equal-Weight
View All

Elanco Animal Health Inc Stock (ELAN) Latest News

pulisher
02:54 AM

Elanco launches cattle respiratory vaccine - Beef Magazine

02:54 AM
pulisher
Jul 15, 2025

Are Options Traders Betting on a Big Move in ELAN Stock? - Yahoo Finance

Jul 15, 2025
pulisher
Jul 13, 2025

Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement - ETX View

Jul 13, 2025
pulisher
Jul 10, 2025

Neurizon, Elanco sign deal to advance ALS therapy NUZ-001 - ALS News Today

Jul 10, 2025
pulisher
Jul 09, 2025

Elanco gets US Agriculture department nod for TruCan (ELAN:NYSE) - Seeking Alpha

Jul 09, 2025
pulisher
Jul 09, 2025

Elanco's dog flu vaccine gets USDA nod - Reuters

Jul 09, 2025
pulisher
Jul 09, 2025

USDA Approves Elanco's New Vaccine for Canine Influenza - MarketScreener

Jul 09, 2025
pulisher
Jul 09, 2025

Elanco receives USDA nod for Trucan Ultra Civ canine flu vaccine - MarketScreener

Jul 09, 2025
pulisher
Jul 09, 2025

Revolutionary Canine Flu Vaccine Shows 100% Protection: Elanco's New TruCan Ultra Gets USDA Green Light - Stock Titan

Jul 09, 2025
pulisher
Jul 08, 2025

Elanco Animal Health (ELAN) Shares Soar 1.94% Amid KBC Group NV Stake Reduction - AInvest

Jul 08, 2025
pulisher
Jul 06, 2025

Levi & Korsinsky Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - ACCESS Newswire

Jul 06, 2025
pulisher
Jul 03, 2025

Shareholder Alert: Johnson Fistel, LLP Investigates Elanco Animal Health, Masimo, Fidelity National Information, and Super Micro Computer —Long-Term Investors are Encouraged to Contact the Firm - GlobeNewswire

Jul 03, 2025
pulisher
Jul 02, 2025

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 - Nasdaq

Jul 02, 2025
pulisher
Jul 02, 2025

The Analyst Verdict: Elanco Animal Health In The Eyes Of 4 Experts - Benzinga

Jul 02, 2025
pulisher
Jun 28, 2025

Duff & Phelps Provided a Fairness Opinion to Elanco in Connection with its Agreement to Acquire Bayer's Animal Health Business - Kroll

Jun 28, 2025
pulisher
Jun 26, 2025

Elanco Releases 2024 Impact Report and Introduces New Framework - ACCESS Newswire

Jun 26, 2025
pulisher
Jun 26, 2025

Elanco Animal Health: A Catalyst-Driven Revaluation in Agri-Sciences - AInvest

Jun 26, 2025
pulisher
Jun 18, 2025

Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded. - Barron's

Jun 18, 2025
pulisher
Jun 18, 2025

Elanco (ELAN) Gains Attention Amid Competitive Market Shifts | E - GuruFocus

Jun 18, 2025
pulisher
Jun 16, 2025

United States Veterinary Pain Management Market Size, Share & - openPR.com

Jun 16, 2025
pulisher
Jun 14, 2025

Harbor Capital Advisors Inc. Has $9.41 Million Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Jun 14, 2025
pulisher
Jun 13, 2025

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from - GuruFocus

Jun 13, 2025
pulisher
Jun 12, 2025

Elanco (ELAN) Awaits European Approval for Zenrelia in Dogs - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco gains positive EMA opinion for Zenrelia for itching in dogs - Seeking Alpha

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco (ELAN) Awaits EU Approval for Veterinary Drug Zenrelia | ELAN Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco’s dog allergy treatment Zenrelia gets positive EU opinion By Investing.com - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco Gets 'Positive Opinion' on Canine Itch Drug From European Medicines Agency - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) | ELAN Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco Receives Positive Opinion On Zenrelia From EU's Committee - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) – Company AnnouncementFT.com - Financial Times

Jun 12, 2025
pulisher
Jun 12, 2025

BiomEdit CEO: Next gen designer probiotics will disrupt the animal and human health market - AgFunderNews

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) - PR Newswire

Jun 12, 2025
pulisher
Jun 11, 2025

ELAN Q1 Earnings Call: Innovation and Product Launches Drive Outlook Amid Macro Uncertainty - Yahoo Finance

Jun 11, 2025
pulisher
Jun 10, 2025

Dog Owner Defends Tick Meds Suit Against Elanco, Retailers - Law360

Jun 10, 2025
pulisher
Jun 10, 2025

What Makes Elanco Animal Health (ELAN) a New Buy Stock - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Jun 10, 2025
pulisher
Jun 09, 2025

Is the Options Market Predicting a Spike in Elanco Animal Health Stock? - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

Veterinary Vaccines Market Set to Surge as Global Demand - openPR.com

Jun 09, 2025
pulisher
Jun 09, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of “Hold” by Analysts - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

Report reveals widespread impact of chronic itch in dogs - Veterinary Practice News

Jun 06, 2025
pulisher
Jun 06, 2025

Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 06, 2025

Elanco Animal Health Appoints Robert VanHimbergen as Chief Financial Officer - Pet Age

Jun 06, 2025
pulisher
Jun 05, 2025

Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief | ELAN Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

Equine Healthcare Market Analysis: Trends, Key Players, - openPR.com

Jun 04, 2025
pulisher
Jun 03, 2025

Animal Depression Medication Market Detailed in New Research Report | Zoetis Inc., Elanco Animal Health - openPR.com

Jun 03, 2025
pulisher
Jun 02, 2025

Ameriprise Financial Inc. Has $1.18 Million Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

Companion Animal Health Market -Depth Analysis, Future Trends - openPR.com

May 30, 2025
pulisher
May 30, 2025

Veterinary Vaccines Market Size, Share & Forecast 2025-2033 | - openPR.com

May 30, 2025
pulisher
May 30, 2025

Cetera Investment Advisers Purchases 4,553 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

May 30, 2025
pulisher
May 29, 2025

Elanco at Stifel Jaws & Paws: Strategic Growth and Innovation By Investing.com - Investing.com Canada

May 29, 2025
pulisher
May 29, 2025

Elanco appoints Robert VanHimbergen as chief financial officer - Feed Strategy

May 29, 2025

Elanco Animal Health Inc Stock (ELAN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$74.41
price down icon 8.43%
$9.08
price up icon 1.68%
drug_manufacturers_specialty_generic RDY
$14.61
price up icon 0.55%
$133.48
price up icon 1.71%
$298.16
price up icon 1.68%
Cap:     |  Volume (24h):